{"id":"W4378640342","doi":"10.1111/jdv.19232","title":"Upadacitinib for moderate‐to‐severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Cilag; LEO Pharma; Galderma; Regeneron Pharmaceuticals; AbbVie; L'Oreal USA; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Key (lock); Baseline (sea); Dermatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009764921,0.001258596,0.004021334,0.0007205688,0.0004384481,0.001756574,0.0007791158,0.001152877,0.004154915],"category_scores_gemma":[0.008252013,0.0005324256,0.009281284,0.00114587,0.0006904161,0.001039656,0.000703617,0.001631139,0.0003542587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007033082,"about_ca_system_score_gemma":0.001543352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004052244,"about_ca_topic_score_gemma":0.001341053,"domain_scores_codex":[0.994022,0.003413341,0.0006500708,0.0008293451,0.0005436546,0.0005415697],"domain_scores_gemma":[0.9941618,0.002646292,0.001758975,0.0006364759,0.0003095819,0.0004868466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9157391,0.001540388,0.01695792,0.00198742,0.03933844,0.0001042696,0.00009414886,0.00133755,0.002937023,0.0001416853,0.0009519722,0.01886997],"study_design_scores_gemma":[0.7111109,0.07678845,0.118437,0.0004103683,0.08426244,0.0003574655,0.0001352809,0.002777904,0.001576769,0.001151006,0.002860309,0.000132231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762051,0.01308153,0.001920284,0.0002959147,0.0001448525,0.003549154,0.003080184,0.0001081915,0.001614937],"genre_scores_gemma":[0.9912209,0.001847861,0.0009563367,0.0004252891,0.00006472654,0.002677653,0.002344373,0.00002910242,0.0004338162],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009764921,"threshold_uncertainty_score":0.05164248,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04383005266787829,"score_gpt":0.3365443378977821,"score_spread":0.2927142852299038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}